|
271 Companies |
|
374 Products |
|
374 Products |
|
160 Mechanisms of Action |
|
34 Trials |
|
5514 News |
|
| «12...6566676869707172737475...110111» |
- |||| Visanne (dienogest) / Mochida, Bayer
Trial completion: VISADO: Visanne Study to Assess Safety in Adolescents (clinicaltrials.gov) - Jun 2, 2014
P2, N=111, Completed, Sponsor: Bayer
Active, not recruiting --> Completed
- Trial primary completion date, MRI: Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. (clinicaltrials.gov) - Jun 1, 2014
P=N/A, N=240, Recruiting, Sponsor: University of California, Los Angeles
Active, not recruiting --> Completed Trial primary completion date: Aug 2013 --> Jun 2014
- ||| estradiol sulfamate (PGL2001) / Gedeon Richter
Enrollment change: AMBER: PGL2001 Proof of Concept Study in Symptomatic Endometriosis (clinicaltrials.gov) - Jun 1, 2014
P2, N=162, Completed, Sponsor: PregLem SA
Trial primary completion date: Aug 2013 --> Jun 2014 N=132 --> 162
- Enrollment open: Human Papillomavirus and Rate of Pregnancy Achieved Via Medically Assisted Procreation (clinicaltrials.gov) - Jun 1, 2014
P=N/A, N=700, Recruiting, Sponsor: Centre Hospitalier Universitaire de Nīmes
N=132 --> 162 Not yet recruiting --> Recruiting
- |||| estradiol sulfamate (PGL2001) / Gedeon Richter
Trial completion: AMBER: PGL2001 Proof of Concept Study in Symptomatic Endometriosis (clinicaltrials.gov) - Jun 1, 2014
P2, N=162, Completed, Sponsor: PregLem SA
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | bentamapimod (PGL5001) / Gedeon Richter
Trial completion: PGL5001 Proof of Concept Study in Inflammatory Endometriosis (clinicaltrials.gov) - Jun 1, 2014
P2a, N=24, Completed, Sponsor: PregLem SA
Active, not recruiting --> Completed Recruiting --> Completed
- | letrozole / Generic mfg., clomifene citrate / Generic mfg.
Trial completion: AMIGOS: Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation (clinicaltrials.gov) - Jun 1, 2014
P3, N=900, Completed, Sponsor: Yale University
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| trebananib (AMG 386) / Amgen
Enrollment change, Combination therapy: TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer (clinicaltrials.gov) - Jun 1, 2014
P3, N=1015, Active, not recruiting, Sponsor: Amgen
Active, not recruiting --> Completed N=2000 --> 1015
- mapatumumab (HGS-ETR1) / GSK
Enrollment change, Combination therapy, Metastases: Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer (clinicaltrials.gov) - Jun 1, 2014
P1/2, N=9, Active, not recruiting, Sponsor: University Medical Centre Groningen
N=2000 --> 1015 N=42 --> 9
- metformin / Generic mfg.
Enrollment closed: A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women (clinicaltrials.gov) - Jun 1, 2014
P2, N=40, Active, not recruiting, Sponsor: University of Arkansas
N=42 --> 9 Recruiting --> Active, not recruiting
- ||||| trebananib (AMG 386) / Amgen
Enrollment closed, Combination therapy: TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer (clinicaltrials.gov) - Jun 1, 2014
P3, N=1015, Active, not recruiting, Sponsor: Amgen
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- mapatumumab (HGS-ETR1) / GSK
Enrollment closed, Combination therapy, Metastases: Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer (clinicaltrials.gov) - Jun 1, 2014
P1/2, N=9, Active, not recruiting, Sponsor: University Medical Centre Groningen
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- || carboplatin / Generic mfg., paclitaxel / Generic mfg., decitabine / Generic mfg.
New P2/3 trial, Metastases: Lower Dose Decitabine (DAC)-Primed TC (Carboplatin-Paclitaxel) Regimen in Ovary Cancer (clinicaltrials.gov) - May 31, 2014
P2/3, N=500, Recruiting, Sponsor: Chinese PLA General Hospital
- Trial primary completion date: Human Chorionic Gonadotrophin in an Antagonist Protocol (clinicaltrials.gov) - May 30, 2014
P2/3, N=60, Recruiting, Sponsor: Cairo University
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2013 --> May 2014
- | Trial initiation date: Human Chorionic Gonadotrophin in an Antagonist Protocol (clinicaltrials.gov) - May 30, 2014
P2/3, N=60, Recruiting, Sponsor: Cairo University
Trial primary completion date: Sep 2013 --> May 2014 Initiation date: Feb 2013 --> Aug 2013
- leuprolide acetate for depot suspension / Generic mfg.
New P4 trial: SIU-LNG: Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis (clinicaltrials.gov) - May 30, 2014
P4, N=44, Completed, Sponsor: University of Sao Paulo
- New P1/2 trial: Pregnancy After Stem Cell Transplantation in Premature Ovarian Failure (clinicaltrials.gov) - May 29, 2014
P1/2, N=10, Completed, Sponsor: Al-Azhar University
- sorafenib / Generic mfg.
Enrollment change, Metastases: Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer (clinicaltrials.gov) - May 29, 2014
P2, N=56, Completed, Sponsor: National Cancer Institute (NCI)
Initiation date: Feb 2013 --> Aug 2013 N=74 --> 56
- sorafenib / Generic mfg.
Trial completion, Metastases: Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer (clinicaltrials.gov) - May 29, 2014
P2, N=56, Completed, Sponsor: National Cancer Institute (NCI)
N=74 --> 56 Active, not recruiting --> Completed
- | Yselty (linzagolix) / Kissei, Theramex, Syneos Health
Trial completion: A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis (clinicaltrials.gov) - May 28, 2014
P2, N=20, Completed, Sponsor: Kissei Pharmaceutical Co., Ltd.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Yselty (linzagolix) / Kissei, Theramex, Syneos Health
Trial completion: A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2) (clinicaltrials.gov) - May 28, 2014
P2, N=100, Completed, Sponsor: Kissei Pharmaceutical Co., Ltd.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
Trial completion date: Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED) (clinicaltrials.gov) - May 28, 2014
P3, N=3882, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Trial completion date: Jun 2004 --> Aug 2008
- Trial completion: RVMM Study: Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women (clinicaltrials.gov) - May 28, 2014
P0, N=30, Completed, Sponsor: Western University, Canada
Trial completion date: Jun 2004 --> Aug 2008 Not yet recruiting --> Completed
- Cycloset (bromocriptine) / Bausch Health
Trial primary completion date: Vaginal Bromocriptine for Treatment of Adenomyosis (clinicaltrials.gov) - May 28, 2014
P1, N=33, Recruiting, Sponsor: Mayo Clinic
Not yet recruiting --> Completed Trial primary completion date: Mar 2014 --> Mar 2016
- Cycloset (bromocriptine) / Bausch Health
Trial completion date: Vaginal Bromocriptine for Treatment of Adenomyosis (clinicaltrials.gov) - May 28, 2014
P1, N=33, Recruiting, Sponsor: Mayo Clinic
Trial primary completion date: Mar 2014 --> Mar 2016 Trial completion date: Jun 2014 --> Jun 2016
- || New P3 trial: Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response? (clinicaltrials.gov) - May 27, 2014
P3, N=140, Recruiting, Sponsor: Cairo University
- | Enrollment open: Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response? (clinicaltrials.gov) - May 27, 2014
P3, N=140, Recruiting, Sponsor: Cairo University
Trial completion date: Jun 2014 --> Jun 2016 Not yet recruiting --> Recruiting
- Trial withdrawal: Safety and Efficacy of Freezing and Thawing of Human Eggs in Assisted Reproductive Technology (clinicaltrials.gov) - May 27, 2014
P=N/A, N=0, Withdrawn, Sponsor: ViaCell
Not yet recruiting --> Recruiting Active, not recruiting --> Withdrawn
- Enrollment change: Safety and Efficacy of Freezing and Thawing of Human Eggs in Assisted Reproductive Technology (clinicaltrials.gov) - May 27, 2014
P=N/A, N=0, Withdrawn, Sponsor: ViaCell
Active, not recruiting --> Withdrawn N=300 --> 0
- Avastin (bevacizumab) / Roche
Clinical: An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer (clinicaltrials.gov) - May 27, 2014
P=N/A, N=3, Completed, Sponsor: Hoffmann-La Roche
- carboplatin / Generic mfg., gemcitabine / Generic mfg.
Enrollment closed, Surgery: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer (clinicaltrials.gov) - May 27, 2014
P1, N=20, Active, not recruiting, Sponsor: Case Comprehensive Cancer Center
N=300 --> 0 Recruiting --> Active, not recruiting
- Avastin (bevacizumab) / Roche
Trial completion: An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian Cancer (clinicaltrials.gov) - May 27, 2014
P=N/A, N=3, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Active, not recruiting Not yet recruiting --> Completed
- Enrollment change, Combination therapy, Metastases: BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer (clinicaltrials.gov) - May 27, 2014
P1, N=19, Active, not recruiting, Sponsor: Boehringer Ingelheim
Not yet recruiting --> Completed N=24 --> 19
- ||||| selurampanel (BGG492) / Novartis
New P2 trial: Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 (clinicaltrials.gov) - May 27, 2014
P2, N=77, Not yet recruiting, Sponsor: Novartis Pharmaceuticals
- metformin / Generic mfg.
Biomarker, Trial primary completion date: Pharmacogenetics of Metformin Action in PCOS (clinicaltrials.gov) - May 26, 2014
P=N/A, N=55, Completed, Sponsor: Virginia Commonwealth University
N=24 --> 19 Trial primary completion date: Apr 2013 --> Sep 2013
- Utrogestan (progesterone) / Besins Healthcare
Preclinical: Implantation Enhancement by Elective Cryopreservation of All Viable Embryos (clinicaltrials.gov) - May 26, 2014
P=N/A, N=212, Recruiting, Sponsor: Universitair Ziekenhuis Brussel
- Neupogen (filgrastim) / Kyowa Kirin, Amgen
Enrollment open: Bone Marrow Stem Cell Treatment for Asherman's Syndrome and Endometrial Atrophy (clinicaltrials.gov) - May 26, 2014
P4, N=18, Recruiting, Sponsor: Valencian Infertility Institute
Trial primary completion date: Apr 2013 --> Sep 2013 Not yet recruiting --> Recruiting
- metformin / Generic mfg.
Biomarker, Trial completion: Pharmacogenetics of Metformin Action in PCOS (clinicaltrials.gov) - May 26, 2014
P=N/A, N=55, Completed, Sponsor: Virginia Commonwealth University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- metformin / Generic mfg.
Biomarker, Enrollment change: Pharmacogenetics of Metformin Action in PCOS (clinicaltrials.gov) - May 26, 2014
P=N/A, N=36, Active, not recruiting, Sponsor: Virginia Commonwealth University
Active, not recruiting --> Completed N=152 --> 36
- Trial primary completion date: [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers (clinicaltrials.gov) - May 26, 2014
P2, N=30, Recruiting, Sponsor: University of Iowa
N=152 --> 36 Trial primary completion date: Dec 2014 --> Dec 2015
- Trial completion date: [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers (clinicaltrials.gov) - May 26, 2014
P2, N=30, Recruiting, Sponsor: University of Iowa
Trial primary completion date: Dec 2014 --> Dec 2015 Trial completion date: Dec 2016 --> Dec 2017
- veliparib (ABT-888) / AbbVie
Enrollment open, Combination therapy, PARP Biomarker, Metastases: Veliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal Cancer (clinicaltrials.gov) - May 26, 2014
P1, N=24, Recruiting, Sponsor: National Cancer Institute (NCI)
Trial completion date: Dec 2016 --> Dec 2017 Active, not recruiting --> Recruiting
- New P3 trial, IO biomarker: Effects of Dehydroepiandrosterone Supplementation on Cumulus Cells Gene Expression Under Controlled Ovarian Hyper-stimulation in Patients With Diminished Ovarian Reserve (clinicaltrials.gov) - May 25, 2014
P3, N=40, Completed, Sponsor: Taipei Veterans General Hospital, Taiwan
- Enrollment open: Transversal, Controlled and Not Randomized Study, Laying on the Desire of Children and Eating Disorders in a Population of Infertile Women (clinicaltrials.gov) - May 25, 2014
P=N/A, N=203, Recruiting, Sponsor: Nantes University Hospital
Active, not recruiting --> Recruiting Not yet recruiting --> Recruiting
- Enrollment closed: Effect of Omega 3 on Atrophic Vaginitis in Breast Cancer Survivors (clinicaltrials.gov) - May 25, 2014
P2, N=52, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Not yet recruiting --> Recruiting Not yet recruiting --> Active, not recruiting
- |||||| Avastin (bevacizumab) / Roche
Enrollment open: A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer (clinicaltrials.gov) - May 25, 2014
P3, N=1000, Recruiting, Sponsor: Hoffmann-La Roche
Not yet recruiting --> Active, not recruiting Active, not recruiting --> Recruiting
- Clinical: Functional Brain Imaging and Psychological Testing in Women With Chronic Pelvic Pain (clinicaltrials.gov) - May 24, 2014
P=N/A, N=48, Not yet recruiting, Sponsor: KK Women's and Children's Hospital
- Trial primary completion date: Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. (clinicaltrials.gov) - May 24, 2014
P4, N=60, Completed, Sponsor: Örebro University, Sweden
Active, not recruiting --> Recruiting Trial primary completion date: Dec 2012 --> Jun 2013
- Trial completion date: Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. (clinicaltrials.gov) - May 24, 2014
P4, N=60, Completed, Sponsor: Örebro University, Sweden
Trial primary completion date: Dec 2012 --> Jun 2013 Trial completion date: Dec 2012 --> Jun 2013
- Trial completion: Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. (clinicaltrials.gov) - May 24, 2014
P4, N=60, Completed, Sponsor: Örebro University, Sweden
Trial completion date: Dec 2012 --> Jun 2013 Recruiting --> Completed